Team:Heidelberg/Delftibactin/DelH

From 2013.igem.org

(Difference between revisions)
m
m
Line 194: Line 194:
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                   <h1>Week 16</h1>
                                   <h1>Week 16</h1>
-
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">We further characterized the DelH plasmid created using Gibson assembly. Unfortunately, none of the screened colonies was for sure positive. Selection of red colonies was not clear, and PCR screened colonies were all negative.
+
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">We further characterized the DelH plasmid created by Gibson assembly. None of the screened colonies yielded definit positive results. Selection of red colonies was not clear, and PCR screened colonies were all negative.
-
In order to avoid high background during screening of the colonies, we decided to run two different strategies. For first approach pHM04, we will amplify the backbone without mRFP, avoiding backbone reassembly due to ribosome binding site homology. In the second strategy pHM05, we will additionally introduce a tetracycline resistance, to ensure integration of the insert.
+
In order to avoid high background during screening of the colonies, we decided to run two different strategies. First, we will amplify the backbone without mRFP, avoiding backbone reassembly due to ribosome binding site homology (pHM04). In the second strategy (pHM05), we will additionally introduce a tetracycline resistance to select for the insert via antibiotic resistance.
In addition to the primers for the new strategies, we designed a new screening primer at the end of DelH. </p>
In addition to the primers for the new strategies, we designed a new screening primer at the end of DelH. </p>
                                 </div>
                                 </div>
Line 205: Line 205:
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                   <h1>Week 17</h1>
                                   <h1>Week 17</h1>
-
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">After performing different Gibson assemblies and screening always resulted in negative clones, the possible explanation could be a religation of the backbone fragment pSB6A1 allowing E.coli to survive and express mRFP. This week, our aim is to design a new construct without mRFP, so that we can exclude the red colonies from the screening. Therefore, we are going to use a new reverse primer for the backbone including only the terminator of the mRFP, but not the mRFP. The primers for the backbone are HM11 & HM17. The construct is named pHM04 and further explained in week 16. </p>
+
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">A possible explanation for the failed Gibson assemblies could be a religation of the backbone fragment pSB6A1 allowing <i>E.coli</i> to survive. In this case, transformed bacteria will still express mRFP. This week, our aim is to design a new construct without mRFP (pHM04), by which we will be able to exclude red colonies from the screening. For this strategy, we are going to use a new reverse primer for the backbone still including the terminator of mRFP, but omitting mRFP itself. The primers for the backbone amplification are HM11 & HM17.</p>
                                 </div>
                                 </div>
                               </div>
                               </div>
Line 214: Line 214:
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                   <h1>Week 18</h1>
                                   <h1>Week 18</h1>
-
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">Because the constructing pHM04 did not result in any positive clone (see experiments week 17), we will follow the idea to introduce a tetracycline resistance to the ampicillin backbone as additional selection marker for successful assembly. So we have to screen only colonies, which are white (because of the exclusion of mRFP) and grow on plates containing tetracycline. Furthermore, we decided to amplify DelH in various fragments to increase Gibson assembly efficiency. Therefore, we also ordered new screening primers. The primers were designed as shown in the following table. </p>
+
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">Since the assembly strategy for pHM04 did not yield positive clones (see experiments week 17), we will follow the idea to introduce a tetracycline resistance to the ampicillin backbone as an additional selection marker for successful assembly. With this approach, positive clones can be easily determined by their white phenotype (exclusion of mRFP) and their ability to grow on plates containing tetracycline. Furthermore, we decided to amplify DelH in various fragments to increase Gibson assembly efficiency. Therefore, we also ordered new screening primers. The primers were designed as shown in the following table. </p>
                                 </div>
                                 </div>
                               </div>
                               </div>
Line 223: Line 223:
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                   <h1>Week 19</h1>
                                   <h1>Week 19</h1>
-
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">After a successful electroporation, we screen numerous clones by colony-PCR and test restriction digest (PvuI-HF). Positive clones are send for sequencing. The sequencing tells us if the DelH Gibson assembly actually worked. Therefore, we send the midipreped plasmids with the reverse DN07 primer or VF2, covering the start sequence of DelH and the end of the pSB6A1 backbone without mRFP (pHM04).
+
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">After successful electroporation, we screened numerous clones by colony-PCR and test restriction digest (PvuI-HF). Midiprepped DNA dervied from clones positive for both methods were sent for sequencing. By sequencing of the transition sequence from the end of the pSB6A1 backbone without mRFP (pHM04) to the beginning of DelH, the assembly success of the Gibson assembly can be determined (Primer: reverse DN07 primer or VF2).Sequencing results showed truncating mutation at the beginning of DelH (in the primer region) for all clones. </p>
-
The screening-PCR showed different positive colonies. After performing the restriction digest, some colonies were discarded and the rest was sent in for sequencing. We did not find any positive clone without a truncating mutation at the beginning of DelH (in the primer region). </p>
+
                                 </div>
                                 </div>
                               </div>
                               </div>
Line 233: Line 232:
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                   <h1>Week 20</h1>
                                   <h1>Week 20</h1>
-
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">Again, the screening-PCRs resulted in many positive colonies. After the restriction digest, many colonies were kicked out. The remaining minipreped colonies were sent in for sequencing. Yet, we did not identify any positive clone which had no mutation at the beginning of DelH (in the primer region). </p>
+
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">As in week 19, the screening-PCRs showed colonies positive for the DelH contatining plasmid, whereas the restriction digest reveiled many of the screening results to be false positive. The remaining miniprepped colonies were sent in for sequencing. Sequencing results showed again truncating mutation at the beginning of DelH (in the primer region) for all clones. </p>
                                    
                                    
                                 </div>
                                 </div>
Line 243: Line 242:
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                   <h1>Week 21</h1>
                                   <h1>Week 21</h1>
-
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">Frustratingly, none of the analyzed clones showed a correct sequence. Probably, DelH by itself is toxic for E.coli and thus, only aberrant clones survive. We suspect the low quality of primers as reason for high number of mutations. Therefore, we will order HPLC purified primers.
+
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">None of the analyzed clones showed a correct sequence, which lead as to the assumptions following assumptions. First, we suspect DelH to be toxic for <i>E.coli</i>, thus only clones carrying the mutant DelH-plasmid survive. Second, we consider the low quality of the gibson primers as a possible explanation for the high number of mutations in the assemblies. To circumwent the latter problem, we will order HPLC purified primers.
Additionally, we tried to eliminate the mutations in DelH clones I 6b and 15 by mutagenesis. Herefore, primers were ordered. </p>
Additionally, we tried to eliminate the mutations in DelH clones I 6b and 15 by mutagenesis. Herefore, primers were ordered. </p>
                                 </div>
                                 </div>
Line 253: Line 252:
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                 <div class="carousel-caption scrollContent2" data-spy="scroll" data-target="#navbarExample" data-offset="0">
                                   <h1>Week 22</h1>
                                   <h1>Week 22</h1>
-
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">So far, we failed to find a single correct DelH clone. We suspect the separate DelH module to be toxic for the E. coli. Therefore, they select for mutated plasmids. In order to reduce the selection pressure, we used E. coli BL21 DE3, known for increased expression of the lac repressor. This strategy also did not result in any correct clone. One reason might be, that the E. coli BL21 DE3 we obtained actually are BL21 DE3 pLys, which are unfortunately Chloramphenicol resistant due to additional plasmid and thus not useful for screening and amplification of DelH construct.
+
                                   <p style="font-size:10pt; text-align:justify; position:relative; margin-left:6%;">So far, we failed to obtain a single correct DelH clone. We suspect the DelH module to be toxic for <i>E. coli</i> when transformed without the other parts of the Del cluster, thus DelH-transformed cells would select for mutated plasmids. In order to reduce the selection pressure, we used <i>E. coli</i> BL21 DE3, known for increased expression of the lac repressor. This strategy also did not result in any correct clone. One reason might be, that the <i>E. coli</i> BL21 DE3 strain we obtained was actually a BL21 DE3 pLys strain, which itself is already Chloramphenicol resistant, thus not useful for screening and amplification of the DelH construct coded for on a chloramphenicol vector.
-
We got new and correct E. coli BL21 DE3 as well as NEB turbo, which significantly overexpress the lac repressor. We however found their lacZ-controlled expression to be very leaky, in contrast to E. coli BL21 DE3.
+
We obtained the correct <i>E. coli</i> BL21 DE3 strain as well as NEB <i>E. coli</i> turbo cells, which significantly overexpress the lac repressor. We found the lacZ-controlled expression of the latter to be very leaky when compared to <i>E. coli</i> BL21 DE3.
-
Since the Gibson assembly of DelH using the HPLC purified primers also exclusively resulted in mutated clones, we developed two new cloning strategies to avoid expression of DelH. The first strategy uses a weak promoter and RBS, the second introduces DelH in a ccdB helper construct. Last but not least, we continued working on the mutagenesis approach to eliminate the mutation in clone C5. It was sent for sequencing... </p>
+
Since the Gibson assembly of DelH using the HPLC purified primers also exclusively resulted in mutated clones, we developed two new cloning strategies to avoid expression of DelH. The first strategy uses a weak promoter and ribosomal binding site, the second introduces DelH in a ccdB helper construct. Lastly, we continued working on the mutagenesis approach to eliminate the mutation in clone C5. It was sent for sequencing... </p>
                                 </div>
                                 </div>
                               </div>
                               </div>

Revision as of 00:18, 3 October 2013

Del H. This bitchy 18 kbp fragment.

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Methods:

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. .